Furthermore, in brains from APP transgenic mice conformation - specific antibodies have revealed the early appearance of intraneuronal fibrillar and oligomeric Aβ immunoreactivity, which
declined as amyloid plaques appeared, and further became evident in the extracellular space [10].
Not exact matches
«Lumpy
amyloid - beta, the stuff we see, ironically doesn't correlate
as well
as with cognitive
decline the soluble
amyloid,» Mitchell said.
Mitchell's latest findings have corroborated the prior study's findings on
amyloid, and also added p - tau
as a key suspect in cognitive
decline.
«The correlation with
amyloid plaque was there but very weak; not nearly
as strong
as the correlation between p - tau and cognitive
decline.»
Also, Alzheimer's diagnosticians might be wise to their adopt cancer colleagues» early detection stance, she said,
as Alzheimer's disease appears to start long before
amyloid - beta plaque appears and cognitive
decline sets in.
Other theories and lines of research have begun to prosper due to the lack of tangible human results for anti-
amyloid immunotherapies, in particular that neurofibrillary tangles of misfolded tau protein are just
as much a target for clearance
as is
amyloid - β, and that perhaps it is time to focus on the
decline of known clearance mechanisms rather than the
amyloid itself.
Identifying the molecular triggers for the onset of AD - related cognitive
decline presently requires the use of suitable animal models, such
as the 3xTg - AD mice, which develop both
amyloid and tangle pathology.
These include insoluble extracellular plaques made of beta -
amyloid peptide (Aβ); intracellular neurofibrillary tangles (NFTs) resulting from the hyperphosphorylation of tau (a microtubule - associated protein); loss of hippocampal neurons; a decrease in production of brain acetylcholine; and a marked
decline in glucose usage in regions of the brain associated with memory and learning.5,11,20 - 22 All of these changes can be logically explained
as the sequelae resulting from long - term dysregulation of insulin signaling and glucose metabolism.